The effect of traditional coronary heart disease risk factors on lifetime risk, age at onset, and survival free of coronary disease has not been extensively studied. The authors have used the cohort data from 27,321 California Seventh-day Adventists who had no known heart disease in 1976 to investigate these questions. Multiple decrement life tables incorporating non-parametric estimates of conditional probabilities for both coronary disease and all other competing endpoints were used to estimate these survival outcomes. Variance estimators are provided in an appendix. Persons characterized by being either past smokers, diabetic, hypertensive, physically inactive, non-vegetarian, or infrequent consumers of nuts often showed substantial differences in these survival outcomes. Statistically significant results include earlier age at onset of coronary disease at between 4 and 10 years, reduced life expectancy free of the disease between 5 and 9 years, and increased lifetime risk between 8% and 16%, when comparing groups with and without adverse values for different risk factors. The presence of adverse levels of two risk factors predicted even greater differences in these endpoints. These important effects are easily understood by the layman or non-epidemiologist professional, which is often not true of a relative risk. This should increase the effectiveness of such results when promoting behavioral change. The effect of many physiologic and life-style variables to increase risk of coronary disease events is now well known. However, the epidemiologic literature has almost exclusively measured their impact on the disease in terms of relative risks. This is a useful concept when assessing causality, but has some disadvantages in other respects. For instance, a relative risk of 0.5 is difficult for non-epidemiologists or the lay public to interpret. Many may have a hazy notion that this means that the risk of heart attack is halved, but they do not realize that this is usually so only for short, defined time periods (often one year), and that there are summary exponential effects over a lifetime. Clearly, the lifetime risk of heart disease is not in general halved. For instance, our cohort of Seventhday Adventists is well known to have a reduction in risk of coronary disease events and cancer when compared with the general population, this being measured Received for publication May 9,1994, and by relative risks substantially less than 1.0 (1). Yet, despite this, cardiovascular diseases (International Classification of Diseases, 9th Revision, codes 390-459 as underlying or immediate cause on the death certificate) account for 56.7 percent of deaths and cancer for 20.9 percent of deaths, which is very similar to proportions found in non-Seventh-day Adventists. Actually, the average age at onset of a disease can be markedly impacted by the effect of the exposure on competing causes. For instance, if the exposure is protective for the disease of interest but hazardous for the aggregate of competing causes, the average age at onset of the disease of interest could be reduced, as few persons remain to be at risk at higher ages, due to deaths from competing causes. If an exposure is hazardous for the disease of interest, then the impact on lifetime risk also depends on whether the exposure affects competing causes. As an example, one could imagine a situation where the effect on competing causes was also hazardous, such that the proportion of persons dying of the disease of interest (i.e., the lifetime risk) was not changed by the exposure. Clearly, the effect of an exposure on outcomes such as lifetime risk and average age at onset is complex and not
by relative risks substantially less than 1.0 (1). Yet, despite this, cardiovascular diseases (International Classification of Diseases, 9th Revision, codes 390-459 as underlying or immediate cause on the death certificate) account for 56.7 percent of deaths and cancer for 20.9 percent of deaths, which is very similar to proportions found in non-Seventh-day Adventists. Actually, the average age at onset of a disease can be markedly impacted by the effect of the exposure on competing causes. For instance, if the exposure is protective for the disease of interest but hazardous for the aggregate of competing causes, the average age at onset of the disease of interest could be reduced, as few persons remain to be at risk at higher ages, due to deaths from competing causes. If an exposure is hazardous for the disease of interest, then the impact on lifetime risk also depends on whether the exposure affects competing causes. As an example, one could imagine a situation where the effect on competing causes was also hazardous, such that the proportion of persons dying of the disease of interest (i.e., the lifetime risk) was not changed by the exposure. Clearly, the effect of an exposure on outcomes such as lifetime risk and average age at onset is complex and not estimable by just knowing the relative risk for the disease of interest.
The purpose of this paper is to apply and describe an approach to the analysis of cohort study data that allows the estimation of effects of particular practices or risk factors on the lifetime risk of coronary heart disease, and also how such effects may delay or advance the first expression of coronary disease, taking into account competing risks from other sources of mortality. The methods are illustrated by the use of the risk factors hypertension, diabetes mellitus, exercise habits, obesity status, past cigarette smoking, vegetarian status, and consumption of nuts. While a number of other investigators (2) (3) (4) (5) (6) (7) (8) have developed methods for analyzing epidemiologic data in this fashion, we know of few reports of such applications. We have previously published relative risk analyses for coronary disease from the Adventist Health Study (9, 10) and now reexamine these data with new statistics.
MATERIALS AND METHODS
The Adventist Health Study is a cohort investigation of 34,198 California non-Hispanic white subjects living in Seventh-day Adventist households. The detailed methods have been described elsewhere (11) . Briefly, the population included all volunteers over age 24 years in 1974 who responded to an invitation to participate. Two extensive questionnaires were mailed to participants in 1974 and 1976. The analyses below used the 27,321 subjects who had no previous history of coronary disease at entry to the study and excluded non-Seventh-day Adventist members of study households. Exposure variables chosen for this report include traditional risk factors and two dietary variables that showed significant associations with coronary disease risk in our previous relative risk analyses (9, 10) . The exposure variables were physician-diagnosed hypertension or diabetes mellitus; self-reported height and weight, from which the body mass index (weight (kg)/height (m) 2 ) was calculated; previous cigarette smoking; exercise; and dietary habits. We note that there were too few current smokers in this population for these analyses. Exercise, categorized as low, medium, and high, was a cross-categorization of two questions pertaining to occupational and leisure activities (9) . Dietary assessment was by a semiquantitative food frequency questionnaire (10) . Specifically, the frequency of consumption of nuts was asked in eight categories, ranging from "never consume" to "more than once per day." These were then collapsed to less than once a week, 1-4 times a week, and ^5 times a week. A vegetarian was defined by eating flesh foods less than once per week.
For any particular exposure variable, missing data occurred in 0.8 to 8.8 percent of subjects depending on the variable. Only subjects with missing data for the exposure variable(s) necessary for that particular analysis were excluded. Loss to follow-up occurred in 2.5 percent of subjects during the 6 years, and these were censored as described below in the person-time calculations.
During 1976-1982, a brief annual questionnaire was mailed to ascertain any hospitalizations during that year. Study personnel then visited or communicated with all relevant hospital medical record rooms. Where a diagnosis of cancer or myocardial infarction seemed possible, all histology reports, medical histories and examinations, electrocardiograms, and cardiac enzyme results were microfilmed. A cancer diagnosis required that the histology be confirmed. Fatal and non-fatal coronary heart disease events were diagnosed using published international diagnostic criteria (12) . Deaths were ascertained by several mechanisms. These included the use of church records, computer matching with California state death tapes (1976) (1977) (1978) (1979) (1980) (1981) (1982) , and matching with the National Death Index (1979) (1980) (1981) (1982) .
Three outcome measures are estimated with the use of multiple decrement life tables: 1) lifetime risk; 2) mean age at onset (fatal or nonfatal coronary disease combined); 3) life expectancy free of coronary disease, which allows either onset of the disease (fatal or nonfatal combined) or death from a competing cause as part of a composite endpoint.
Statistical methods
The basic parameters that are first estimated in these analyses are 1) the age-specific conditional probabilities of the disease of interest, and 2) the age-specific conditional probabilities of all other causes of failure (i.e., all other causes of death) that removed subjects from risk of a coronary disease event.
The above probabilities were estimated as follows: Using a non-parametric approach with attained age as the time variable, the unit of time was one year of age. If q d {k) and q c (k) are the conditional probability estimates at age k for the events of the disease of interest and the competing causes of mortality, respectively, then
is the number of new events of disease d during the age interval {k, k + 1), and P(k) is the number of subjects at risk during the kth year of age. Similarly, q c (k) = N c {k)IP{k). We note that under this model, events are mutually exclusive, and a particular subject either survives the age interval, withdraws, develops coronary disease, or experiences a competing event. To accommodate subjects who were scheduled to start or end follow-up at fractional ages, say k + r m (fc) for start of follow-up, or k + s m (k) for end of follow-up, we used
where n subjects contribute time to age k, where s m (k) = 1 except possibly for the final interval, and r m {k) = 0, except possibly for the initial interval. In the case of withdrawal or other censoring at k + t m (k), we calculated s m (k) = t m {k) in the above formula as suggested by Hoem (13).
The highest age at which any event is observed is defined as w,. A final open-ended age interval denoted by w begins with age w 0 , where w 0 is defined as the smaller of 101 years or the greatest age k that is less than or equal tow,, such that the sum of both types of event at all ages greater than k -5 exceeds four. This last is to give a minimum of at least five events with which to estimate the mean survival time through w for those surviving to w 0 .
The life table was closed out using the method described by Manton and Stallard (14) , where data from ages w 0 -5 to w, years were used to estimate conditional probabilities q c (w), q d (w), and C/ w . Then
and similarly for q c (w). In the formulae for e d (y) and e d+c (y) below, the value of U k = k + 0.5 when k < w 0 , with the 0.5 reflecting the assumption of a uniform distribution of deaths during one year of age. When
the latter expression being the estimated mean age at death for those surviving to w 0 using the inverse of the estimated total event rate.
Then using the multiple decrement life table approach (14) , it is possible to estimate e d (y), which is the life expectancy free of disease d among those persons who will eventually develop disease d. In all that follows, we call e d (y), the mean age at onset, where observation begins at age y. This can be written algebraically in a number of ways.
We have used the following equation: The second outcome measure, life expectancy free of disease d, is estimated by Note that a i and b t are independent as they result from analyses of separate populations (i.e., those exposed or nonexposed).
If the test of effect modification is nonsignificant (p > 0.10), differences in the outcome measure by risk factor status are summarized (5) over the two sexes using a weighted average of the sex-specific differences. The weights are the inverses of the respective variance estimates.
Hence, Table 5 evaluates the effect of selected pairs of risk factors operating together, where those combinations selected were all the combinations where there were at least 20 coronary disease events and 20 complimentary events, so as to approximately preserve the large sample normality of the outcome measures.
These tables show that the predicted age at onset among those who develop coronary disease is substantially earlier in diabetics, hypertensives, past smokers, the inactive, and males. This was possibly also true for relatively obese women. The predicted number of years of life expectancy free of coronary disease was significantly less in males, the inactive, diabetics, low nut consumers, and hypertensives. The predicted lifetime risk of the disease was significantly greater in diabetics, hypertensives, and low nut consumers. This was also true for obese males and non-vegetarian males. In general, the pairwise combinations of the variables showed qualitatively similar differences to those seen with the constituent individual factors, but are often of substantially greater magnitude, as might have been expected.
The above results all pertain to subjects in whom the nominated exposure status was present by age 30 years and the life table begun at that age (i.e., y = 30 in the equations of the "Statistical methods" section). The corresponding results for subjects free of the disease and starting the life 
DISCUSSION
One motivation for these analyses was our belief that it is important to present results of risk factor analyses in a way that the layman and the nonepidemiologist professional can readily grasp. This has not always been true with the relative risk approach, which we believe is usefully complemented by analyses such as those presented here. The potential for good compliance with medications or change in behavior is enhanced if the patient has a clear understanding of the possible consequences of his/her actions. An extension of years free of coronary disease or a reduction in lifetime risk of the disease are concepts that can be readily understood by most people. Such results can also be applied to populations. Then it may be possible to estimate the average number of years of deferral of onset of coronary disease in the population, or the proportion of the population who will develop the disease if a preventive policy is enacted. Clearly, this would be very useful information for both the planning of health policy and the estimation of the necessary public health resources. As usual, a policy maker must also consider the effects of such possible interventions on other clinical endpoints.
However, it is important to point out that these are univariate results (aside from control of gender), and that some confounding between variables is likely. It can be stated that in this data set relative risk analyses adjusting only for age and sex gave estimates for all of these variables (except vegetarianism) quite close to those found when all variables were included together in the model. This suggests that confounding is minor in relative risk analyses. Whether such confounding as there is would have a greater effect on survival outcomes compared with relative risks is unknown. Consequently, our results as presented above should be used cautiously for etiologic arguments, but are useful for prediction. A multivariate approach is necessary to effectively deal with confounding.
The results shown in tables 2-4 contain predictions of substantial differences between exposure subgroups. For any particular endpoint, there is generally good concordance between the sexes, with the exception of body mass index and vegetarian status. In females, body mass index is not related to the lifetime risk of coronary disease, but, among persons who are predicted to develop the disease, the obese do so 8.7 years earlier (p < 0.10). However, obese males have a 16.3 percentage points greater lifetime risk than do males in the lowest body mass index tertile (p < 0.05), whereas age at onset in males does not depend on the body mass index value. One implication may be that in obese females the disease process in those who are susceptible is accelerated, whereas in obese males a higher proportion are sensitized (or initiated) but the disease is not accelerated. As in relative risk analyses, we again find that for men compared with women vegetarian status appears to be more important for coronary disease. The only survival outcome affected by vegetarianism is lifetime risk, which is 13.1 percentage points greater in non-vegetarian males than vegetarian males (p < 0.05), while in females, vegetarianism has no apparent impact. Such a difference between the sexes in the effect of diet on coronary disease risk has been postulated by other investigators (15) .
Our data predicted that, compared with females, males have a 4.5 percentage points greater lifetime risk of coronary disease (NS), and males who develop the disease experience onset 9.3 years earlier than do females who develop it (p < 0.001). Thus, despite the fact that this is a relatively low risk population (16) , there still remains a substantial advantage in being female with respect to risk of coronary disease.
Diabetes mellitus, as one might expect from common clinical experience, has major effects in accelerating the expression of coronary disease in susceptible persons, and also in increasing the lifetime risk of coronary disease. Relatively large effects on all endpoints were found in our data. These effects are quite consistent for both males and females. Knuiman et al. (17) found in Australia that the life expectancy of type II diabetics compared with non-diabetics at age 45 years was decreased by 11.4 years in females and by 3.5 years in males. While we did not report life expectancy data, this should not greatly differ from our endpoint "life expectancy free of coronary disease." In fact, our results for all diabetics were quite similar for both sexes and fall between the male and female results reported by Knuiman et al. (17) .
Hypertensives also experience both an 11.0 percentage points greater lifetime risk of coronary disease (p < 0.001) and an earlier expression of the disease by 4.5 years in susceptible persons (p < 0.05). In this well-educated population (11), 49.6 percent of those subjects who had "ever been told by a doctor" that they had high blood pressure were also on antihypertensive therapy in 1976. Presumably, untreated current hypertensives in 1976 would have shown even greater adverse effects. The survival experience of past smokers was also of interest. Although about 19 percent of our subjects had been past smokers, the average duration of church membership for those persons was 23.7 years. Hence, these data seem to indicate either a long-term persisting effect of cigarette smoking (which our multivariate risk ratio analyses also suggested (10)), or that the past smokers have adverse values of other risk factors.
We note the apparent salutary effect of frequent nut consumption (>5 times per week). On average, persons characterized by this simple dietary habit have a 12.4 percentage points lower lifetime risk of coronary disease (p < 0.05), and males who develop the disease do so 5.6 years later than males who consume few nuts (NS). Whether this is causal or not needs further investigation, but our previous multivariate risk ratio analyses found little evidence of confounding (10) and at least one other major cohort study has reported similar risk ratio findings (18) for nut consumption. Table 5 shows predicted survival experience based on selected pairs of risk factors, where both factors take either high or low risk values. These analyses suffer from lower numbers and hence lower statistical power. However, there are few surprises or evidence of effect modification. The predicted differences in survival experience between the contrasting subgroups are often very substantial. However, such pairwise combinations of such risk factors are not at all uncommon in the population. Clearly, the analysis of effects of several variables jointly will be more efficient and is often only possible with multivariate techniques that should improve statistical power but require more assumptions. The Adventist Health Study cohort of 34,198 subjects followed for 6 years has some advantages for these types of analyses. Subjects entered the cohort with no upper age limit, with the oldest subject being 105 years and with 309 other subjects aged at least 90 years at entry. Thus, we were able to make reasonable estimates of conditional probabilities of disease right through to the end of the life cycle. Other studies have often not had this advantage (19) (20) (21) . A problem with most longitudinal studies (the Adventist Health Study included) is the lack of repeated observations on risk factor values during significant periods of the life-span of each individual. We, for instance, evaluate conditional probabilities of coronary disease in hypertensives at all ages after the starting age. Hence, our analyses test the effect of having hypertension contin-uously after this starting age, compared with its continued absence. While this is of interest, the abnormal risk factor value may develop only part way through the life-span. Thus, such results reflect the extreme, but not uncommon, circumstance of exposure to these conditions throughout adult life. An advantage in our data was the general focus on habits (e.g., diet, exercise) or obesity that typically remain fairly constant (22) (23) (24) , at least in a relative sense, throughout long periods. Results where the starting age for the life tables was 60 years are generally very similar to those starting at age 30 years, except for a modest reduction in the magnitude of the differences.
We also remind the reader that the current life table approach to analysis requires the construction of a synthetic cohort. That is, it does not represent the actual life experience of any existing population, rather, the conditional probabilities found for persons at a particular age during the study are assumed to apply during that same year of age of the synthetic life table population as it ages. There is no account taken of probable secular trends in the conditional probabilities. Nevertheless, this approach does form a rational basis for comparison of the effects of different exposures.
The relation between risk ratios and life expectancy is known to be complex. Keyfitz (25) , Vaupel (26) , and Tsai et al. (27) have shown that a fixed percentage change in mortality that applies at all ages is related to the percent change in life expectancy by a multiplying factor, where this factor is a complex measure of the way that the underlying mortality changes with age in the population. Thus, a different pattern of mortality with age in some population may alter the way that a constant relative risk will affect life expectancy. These considerations do help us understand how different underlying patterns of change in mortality with age may produce different effects on life expectancy, with the same constant risk ratios.
It is of interest to note in our data that, while in most cases a relative risk for coronary disease greater than one is associated with both a higher lifetime risk and a lower expected age at onset, this is not always so. Low nut consumption in females, non-vegetarianism in males, and high body mass index in males are all apparently associated with a substantial increase in lifetime risk but little or no effect on age at onset. From theoretical considerations and confirmed by numerical exploration, it can be shown that 1) lifetime risk of coronary disease is strongly positively associated with relative risk for the disease and strongly negatively associated with relative risk for competing causes, and 2) age at onset is strongly negatively associated with the relative risk for competing causes and only weakly negatively associated with the relative risk for coronary disease. The results hold when q d (k) and q c (k) take values similar to those that we observed. It does assume a constant relative risk across all ages. Hence, our speculation in the introduction that the effects of the exposure on competing causes will also be important is borne out here. Table 6 shows the non-parametric (MantelHaenszel) relative risks of both coronary disease and competing causes, for both sexes combined (when appropriate), according to exposure levels. Comparison of these relative risks with the survival outcomes of tables 2-4 generally shows the expected correspondence. As commented earlier, the survival outcomes are influenced by effects of the exposure on both coronary disease and competing causes. In most instances, the relative risk effects (table 6) are greater for coronary disease than the competing cause. Adding to this already complex scenario, the Mantel-Haenszel relative risks assume uniform effects among the four age strata, whereas in the survival calculations, no constraints were placed on the conditional probabilities, which could change from year to year, or in a more general sense may tend to be quite different in older compared with younger persons. Such differences will somewhat obscure detailed comparisons with the non-parametric relative risks in this table.
A few previous studies (19) (20) (21) have performed analyses that have some similarity to those we present here. Three reports have used age-specific Framingham Study mortality and coronary disease incidence data in life table analyses. These studies have evaluated the effects of one or more of the traditional risk factors (weight, blood pressure, blood cholesterol, and cigarette smoking) or a lipid lowering diet. Typically, the estimates of effect were rather smaller than those that we report. Tsevat et al. (21) looked only at changes in life expectancy predicted to result from changes in the above risk factors. Grover et al. (19) evaluated the predicted effects of treating hyperlipidemia on both life expectancy and life expectancy free of coronary disease. The effect of a risk factor on life expectancy would often be less than its impact on a coronary disease survival endpoint. Taylor et al. (20) focused on serum cholesterol reduction, but also predicted the effects of smoking cessation and blood pressure reduction on life expectancy.
Direct comparisons between our data and these reports are difficult for a number of reasons. These include different definitions of exposure variables, the use of extrapolation in other studies for the older ages, mixing of data from two populations in some reports, and the fact that our analyses assume continual exposure and are non-parametric in nature. Our nonparametric analyses suffer from reduced power compared with a multivariate modeling approach, but are not reliant on goodness-of-fit to such a model. Such univariate results do not account for confounding, but should still give an unbiased prediction of the experience of a group defined only by the presence or absence of the exposure.
Can these results from a modestly lower risk Seventh-day Adventist population (16) be applied to the general population? We have reported (9) relative risks for coronary disease from this same population that are very similar to those found in the Framingham Study and many other studies. However, as discussed above, if the underlying mortality patterns with age are different from those of the general population, the changes that we predict in survival may differ somewhat from those predicted for the general population. Nevertheless, numerical exploration over a moderate range of conditional probabilities in unexposed subjects, and keeping relative risk levels for both coronary disease and competing events in the exposed constant, suggests that although the absolute levels of the coronary disease survival endpoints may change moderately, the difference in values with and without exposure (i.e., the effect) changes very little. Hence, our results may be approximately applicable to nonAdventist populations.
In summary, we have demonstrated that subgroups of California Seventh-day Adventists characterized by different values of coronary disease risk factors show important differences in predicted lifetime risk of the disease, age at onset, and life expectancy free of coronary disease. These associations were generally consistent for males and females. If these risk factors are causal, there are important public and personal health implications.
where and
= S t -y) ~-(*/, -y)] S( W )-P(k) \og\\-N T IP T ){P T -N T Y
Note that the variances of the conditional probabilities q(J) are estimated as functions of these observed statistics rather than the underlying binomial parameters, 6(j) = E[q(j)]. Provided that numbers are reasonably large, this should be satisfactory. However, even in a relatively large data set such as ours, with some subgroup analyses, zero cases were sometimes observed for a particular age group. This would predict a variance (q) = 0 if the above approach is used. Clearly, this would be an underestimate. Hence, for variance estimation only, we grouped our observations and person-years to 5 In the rare instance that there were no events observed for a whole 5-year age range (over the age of 50 years), we elected to use a conservative estimate of 6 d (k) or 6 c (k). A value of, say, d d (k) was chosen such that there would have been a probability of only 0.1 of observing a value as low as zero for all five consecutive years given the observations for the c endpoint, under a binomial distribution. A similar approach has previously been suggested for an accounting application (28) . in the few occasions where it is appropriate.
